Doctors Larry Weisenthal and William Grace have collaborated for 36 years on testing anti-cancer drugs in the tissue cultures of actual cancer patients.
In pursuit of effective therapies, they discovered a compound that dramatically increases the effectiveness of standard chemotherapeutic agents.
The compound has worked in more than a dozen liquid and solid tumors, in some instances curing cancers currently thought of as incurable. Cytometric Therapeutics has begun to prepare for clinical trials in 2024.